Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)

Introduction Colorectal cancer (CRC) is still associated with poor prognosis, especially in patients with advanced disease. Development of new prognostic tools replacing or supplementing those routinely used is definitely needed, with the aim to optimise and personalise treatment strategies. Gut mic...

Full description

Bibliographic Details
Published in:BMJ Open
Main Authors: Benoit Chassaing, Nicolas Barnich, Pierre Sauvanet, Denis Pezet, Julie Veziant, Karine Poirot, Caroline Chevarin, Lucie Cassagnes, Frederic Robin, Catherine Godfraind, Mathilde Bonnet
Format: Article
Language:English
Published: BMJ Publishing Group 2020-01-01
Online Access:https://bmjopen.bmj.com/content/10/1/e031472.full